Steve Pakola

Track

Insider profile

Steve Pakola's trades of Regenxbio Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-13 2026-05-11
US Regenxbio Inc (RGNX)
PlS Planned sale
13,387 +27.9%
230.59
US$4,293,989 		13,387 +27.9% 230.59 US$4,293,989
2026-05-11 2026-05-11
US Regenxbio Inc (RGNX)
PrS Proposed sale
6,791
133.83
US$4,245,353 		6,791 133.83 US$4,245,353
2026-03-12 2026-03-10
US Regenxbio Inc (RGNX)
PlS Planned sale
75,460 +48.2%
455.83
US$2,089,562 		75,460 +48.2% 455.83 US$2,089,562
2026-03-10 2026-03-10
US Regenxbio Inc (RGNX)
PrS Proposed sale
5,124
10.38
US$53,187 		5,124 10.38 US$53,187
2024-03-07 2024-03-05
US Regenxbio Inc (RGNX)
PlS Planned sale
12,878 -10.7%
28.36
US$365,220 		12,878 -10.7% 28.36 US$365,220
2024-03-05 2024-03-05
US Regenxbio Inc (RGNX)
PrS Proposed sale
12,878
21.36
US$275,074 		12,878 21.36 US$275,074
2024-01-04 2024-01-03
US Regenxbio Inc (RGNX)
PlS Planned sale
17,237 -13.9%
17.39
US$299,789 		17,237 -13.9% 17.39 US$299,789
2024-01-03 2024-01-03
US Regenxbio Inc (RGNX)
PrS Proposed sale
17,237
18.34
US$316,127 		17,237 18.34 US$316,127
2023-01-05 2023-01-03
US Regenxbio Inc (RGNX)
PlS Planned sale
3,138 -20.5%
22.17
US$69,559 		3,138 -20.5% 22.17 US$69,559
2022-01-04 2022-01-03
US Regenxbio Inc (RGNX)
PlS Planned sale
1,598 -16.2%
33.75
US$53,932 		1,598 -16.2% 33.75 US$53,932